Skip to main content

Advertisement

Log in

Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition; however, many of the traditional therapies used in clinical practice fail to show efficacy when subjected to large randomized placebo-controlled trials. This may be because CP/CPPS is a heterogeneous syndrome rather than a specific disease which would explain the failure of “one size fits all” therapy. In order to direct appropriate therapy, we have developed a six-point clinical phenotyping system to evaluate patients with chronic urologic pelvic pain. The clinical domains are urinary symptoms, psychosocial dysfunction, organ-specific findings, infection, neurologic/systemic, and tenderness of muscles, which produces the acronym UPOINT. Each domain is diagnosed clinically and is associated with specific therapies. This approach is simple and has proven effective in our hands for patients even after many years of failed therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shoskes DA (2008) Chronic prostatitis/chronic pelvic pain syndrome. Humana Press

  2. Persson BE, Ronquist G (1996) Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J Urol 155:958

    Article  PubMed  CAS  Google Scholar 

  3. He L, Wang Y, Long Z, Jiang C (2010) Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis. Urology 75:654

    Article  PubMed  Google Scholar 

  4. Westesson KE, Shoskes DA (2010) Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat? Curr Urol Rep 11:261

    Article  PubMed  Google Scholar 

  5. Pontari MA, McNaughton-Collins M, O’leary MP, Calhoun EA, Jang T, Kusek JW, Landis JR, Knauss J, Litwin MS (2005) A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 96:559

    Article  PubMed  Google Scholar 

  6. Tripp DA, Nickel JC, Wang Y, Litwin MS, McNaughton-Collins M, Landis JR, Alexander RB, Schaeffer AJ, O’Leary MP, Pontari MA, Fowler JEJ, Nyberg LM, Kusek JW (2006) Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 7:697

    Article  PubMed  Google Scholar 

  7. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN (2003) Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 169:592

    Article  PubMed  CAS  Google Scholar 

  8. Nickel JC, Elhilali M, Emberton M, Vallancien G (2006) The beneficial effect of alfuzosin 10 mg once daily in ‘real-life’ practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int 97:1242

    Article  PubMed  CAS  Google Scholar 

  9. Nickel JC, O’Leary MP, Lepor H, Caramelli KE, Thomas H, Hill LA, Hoel GE (2011) Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol 186:125

    Article  PubMed  CAS  Google Scholar 

  10. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O’Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JEJ, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LMJ, Litwin MS (2004) Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 141:581

    Article  PubMed  CAS  Google Scholar 

  11. Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, Shoskes DA, Litwin MS, Alexander RB, White PC, Berger R, Nadler R, O’Leary M, Liong ML, Zeitlin S, Chuai S, Landis JR, Kusek JW, Nyberg LM, Schaeffer AJ (2008) Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359:2663

    Article  PubMed  CAS  Google Scholar 

  12. Shoskes DA (2001) Use of antibiotics in chronic prostatitis syndromes. Can J Urol 8(Suppl 1):24

    PubMed  Google Scholar 

  13. Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J (2003) Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62:614

    Article  PubMed  Google Scholar 

  14. Zhao WP, Zhang ZG, Li XD, Yu D, Rui XF, Li GH, Ding GQ (2009) Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). Braz J Med Biol Res 42:963

    Article  PubMed  CAS  Google Scholar 

  15. Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DEJ, Sant GR (2005) Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 173:1252

    Article  PubMed  Google Scholar 

  16. Goldmeier D, Madden P, McKenna M, Tamm N (2005) Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study. Int J STD AIDS 16:196

    Article  PubMed  Google Scholar 

  17. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54:960

    Article  PubMed  CAS  Google Scholar 

  18. Elist J (2006) Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 67:60

    Article  PubMed  Google Scholar 

  19. Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brahler E, Weidner W (2009) A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 56:544

    Article  PubMed  Google Scholar 

  20. Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, Nickel JC, Shoskes DA, Alexander RB, O’Leary M, Zeitlin S, Chuai S, Landis JR, Cen L, Propert KJ, Kusek JW, Nyberg LMJ, Schaeffer AJ (2010) Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 170:1586

    Article  PubMed  CAS  Google Scholar 

  21. Anderson RU, Wise D, Sawyer T, Glowe P, Orenberg EK (2011) 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol 185:1294

    Article  PubMed  Google Scholar 

  22. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O’Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM (2009) Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 182:570

    Article  PubMed  Google Scholar 

  23. Shoskes DA, Nickel JC, Rackley RR, Pontari MA (2009) Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 12:177

    Article  PubMed  CAS  Google Scholar 

  24. Shoskes DA, Nickel JC, Dolinga R, Prots D (2009) Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 73:538

    Article  PubMed  Google Scholar 

  25. Samplaski MK, Li J, Shoskes DA (2012) Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 188:1788

    Article  PubMed  Google Scholar 

  26. Hedelin HH (2009) Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome. Scand J Urol Nephrol 43:373

    Article  PubMed  Google Scholar 

  27. Magri V, Wagenlehner F, Perletti G, Schneider S, Marras E, Naber KG, Weidner W (2010) Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. J Urol 184:2339

    Article  PubMed  Google Scholar 

  28. Davis SN, Binik YM, Amsel R, Carrier S (2013) Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs “UPOINT” to yes. J Urol 189:146

    Article  PubMed  Google Scholar 

  29. Samplaski MK, Li J, Shoskes DA (2011) Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 78:653

    Article  PubMed  Google Scholar 

  30. Shoskes DA, Nickel JC, Kattan MW (2010) Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75:1249

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel A. Shoskes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shoskes, D.A., Nickel, J.C. Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system. World J Urol 31, 755–760 (2013). https://doi.org/10.1007/s00345-013-1075-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1075-6

Keywords

Navigation